Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry

Bogossian, Harilaos; Frommeyer, Gerrit; Hochadel, Matthias; İnce, Hüseyin; Spitzer, Stefan G.; Eckardt, Lars; Maier, Sebastian; Kleemann, Thomas; Brachmann, Johannes; Stellbrink, Christoph; Gonska, Bernd–Dieter; Kääb, Stefan; Senges, Jochen; Lemke, Bernd

doi:10.1007/s00392-019-01584-x

Cited by 9 publications

(9 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is essentially unchanged from the last analysis of national ICD implant practice in NZ in 2010 . The primary prevention ICD implant ratio reported in several international registries over the past decade is as follows: 46% in Denmark, 55% in Germany, 57% in the United Kingdom, 59% in Sweden, 62% in Spain, 63% in France, 73% in Canada, 75% in the United States, and 82% in Italy . The proportion of ICDs implanted in NZ for primary prevention indications is thus on the lower end of the range of contemporary international implant practice.…”

Section: Discussionmentioning

confidence: 98%

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)

Foo

Lee

Looi

et al. 2019

Journal of Arrhythmia

View full text Add to dashboard Cite

on behalf of the ANZACS-QI investigatorsThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. AbstractBackground: The ANZACS-QI Cardiac Implanted Device Registry (ANZACS-QI DEVICE) collects nationwide data on cardiac implantable electronic devices in New Zealand (NZ). We used the registry to describe contemporary NZ use of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy (CRT). Methods: All ICD and CRT Pacemaker implants recorded in ANZACS-QI DEVICEbetween 1 January 2014 and 31 December 2017 were analyzed. Results:Of 1579 ICD implants, 1152 (73.0%) were new implants, including 49.0% for primary prevention and 51.0% for secondary prevention. In both groups, median age was 62 years and patients were predominantly male (81.4% and 79.2%, respectively).Most patients receiving a primary prevention ICD had a history of clinical heart failure (80.4%), NYHA class II-III symptoms (77.1%) and LVEF ≤35% (96.9%). In the secondary prevention ICD cohort, 88.4% were for sustained ventricular tachycardia or survived cardiac arrest from ventricular arrhythmia. Compared to primary prevention CRT Defibrillators (n = 155), those receiving CRT Pacemakers (n = 175) were older (median age 74 vs 66 years) and more likely to be female (38.3% vs 19.4%). Of the 427 (27.0%) ICD replacements (mean duration 6.3 years), 46.6% had received appropriate device therapy while 17.8% received inappropriate therapy. The ICD implant rate was 119 per million population with regional variation in implant rates, ratio of primary prevention ICD implants, and selection of CRT modality. Conclusion:In contemporary NZ practice three-quarters of ICD implants were new implants, of which half were for primary prevention. The majority met current guideline indications. Patients receiving CRT pacemaker were older and more likely to be female.

show abstract

Section: Discussionmentioning

confidence: 98%

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)

Foo

Lee

Looi

et al. 2019

Journal of Arrhythmia

View full text Add to dashboard Cite

show abstract

“…3,12,37,38 The mean ages of PPM (74.4 years) and ICD (59.2 years) implants are in keeping with those reported in international studies. [26][27][28][29][30] However, there was only a small and non-significant increase in the mean age of patients receiving implants over the study period, which differs from the increasing mean age reported in other international studies. [17][18][19][20]…”

Section: Age-specific Trendsmentioning

confidence: 59%

“…The gender disparity in ICD implants have been reported in multiple studies. 19,20,[22][23][24][27][28][29][30][31][32] However, there was a higher average annual percent increase in new ICD implants for males as compared to females in almost all age-groups, which has not previously been reported. 24,42 Our colleagues have recently shown that despite the overall decline in hospitalisation for acute coronary syndrome for both sexes over the past decade, men continued to have higher hospitalisation rates for acute coronary syndrome compared to women.…”

Section: Sex Differencesmentioning

confidence: 99%

“…[17][18][19][20] Multiple international and local studies have also demonstrated that there is a significant difference in CIED implant rates by sex, particularly for ICDs. 2,[19][20][21][22][23][24][25][26][27][28][29][30][31][32] However, there is limited published data on implant trends by sex-specific age groups. We aimed to provide a contemporary analysis of CIED implant trends by age and sex over the past decade in New Zealand.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Ten year trends in cardiac implantable electronic devices in New Zealand: a national data linkage study (ANZACS-QI 51).

Foo

Stiles

Lee

et al. 2020

Preprint

View full text Add to dashboard Cite

Introduction Implant rates for cardiac implantable electronic devices (CIED), including permanent pacemakers (PPM) and implantable cardioverter defibrillators (ICD), have increased globally in recent decades. This is the first national study providing a contemporary analysis of national CIED implant trends by sex-specific age groups over an extended period. Methods Patient characteristics and device type were identified for ten years (2009 to 2018) using procedure coding in the National Minimum Datasets, which collects all New Zealand (NZ) public hospital admissions. CIED implant rates represent implants/million population. Results New PPM implant rates increased by 4.6%/year (p<0.001), increasing in all age groups except patients <40 years. Males received 60.1% of new PPM implants, with higher implant rates across all age groups compared to females. The annual increase in age-standardised implant rates was similar for males and females (3.4% vs 3.0%, p=0.4). By 2018 the overall PPM implant rate was 538/million. New ICD implant rates increased by 4.2%/year (p<0.001), increasing in all age groups except patients <40 and [?]80 years. Males received 78.1% of new ICD implants, with higher implant rates across all age groups compared to females. The annual increase in age-standardised implant rates was higher in males compared to females (3.5% vs 0.7%, p<0.001). By 2018 the overall ICD implant rate was 144/million population. Conclusion CIED implant rates have increased steadily in NZ over the past decade but remain low compared to international benchmarks. Males had substantially higher CIED implant rates compared to females, with a growing gender disparity in ICD implant rates.

show abstract

“…Gegenüber der Herzschrittmacherimplantation ist die Inzidenz der perioperativen Letalität bei ICD-Implantationen niedriger [ 3 ]. In den deutschen Registerdaten wird die In-hospital-Mortalität zwischen 0,1 % und 1 % beschrieben [ 4 ].…”

Section: Introductionunclassified

Peripoperative Mortalität nach ICD-Implantation

Bogossian

Panteloglou

Karosiene

et al. 2021

Herz

Self Cite

View full text Add to dashboard Cite

Zusammenfassung Hintergrund Implantierbare Kardioverter-Defibrillatoren (ICD) sind zum Schutz vor plötzlichem Herztod bei Patienten mit primär- oder sekundärprophylaktischer Indikation etabliert. Wie bei allen komplexen operativen Verfahren verbleibt auch bei der ICD-Implantation ein Risiko für Komplikationen bis hin zum Tod. Gegenstand der vorliegenden Arbeit ist es, anhand der Datensätze zur obligaten Qualitätssicherung in Nordrhein-Westfalen die prozedurbezogene Mortalität nach ICD-Implantation zu analysieren. Methoden Aus den Datensätzen erfolgte eine Analyse der stationären Todesfälle bei allen 18.625 ICD-Implantationen der Jahre 2010 bis 2012. Ergebnisse Während des stationären Aufenthalts verstarben 118 Patienten (0,6 %) nach ICD-Implantation. Patienten im Alter über 80 Jahre (7 %) zeigten eine höhere Mortalität (1,9 % vs. 0,5 % bei < 80-jährigen Patienten, p > 0,001), ebenso Frauen (0,95 % vs. 0,54 % bei Männern; p = 0,004) und Patienten mit hoher NYHA(New York Heart Association)-Klasse (0,3 % bei NYHA II, 0,7 % bei NYHA III, 3,4 % bei NYHA IV; p < 0,001 für alle Vergleiche). Das Vorliegen von Diabetes mellitus (23 % des Kollektivs) beeinflusste die perioperative Letalität nicht, während eine dialysepflichtige Niereninsuffizienz eine signifikant erhöhte Mortalität aufwies (p < 0,001 gegenüber Patienten mit Kreatinin ≤ 1,5 mg/dl; p = 0,002 gegenüber nicht dialysepflichtigen Patienten mit Kreatinin > 1,5 mg/dl). Patienten mit sekundärprophylaktischer ICD-Indikation wiesen eine signifikant höhere Mortalität auf (1,2 % vs. 0,4 %; p < 0,001), die sich beim Auftreten von Komplikationen von 0,6 % auf 3,7 % erhöhte (p < 0,001). Schlussfolgerung Die operationsbezogene Mortalität bei ICD-Implantation ist bei Patienten über 80 Jahre, hoher NYHA-Klasse, Dialysepflicht, sekundärprophylaktischer Indikation und nach Auftreten von Komplikationen erhöht.

show abstract

Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry

Cited by 9 publications

References 19 publications

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)

Ten year trends in cardiac implantable electronic devices in New Zealand: a national data linkage study (ANZACS-QI 51).

Peripoperative Mortalität nach ICD-Implantation

Contact Info

Product

Resources

About